Practice Parameter:Evaluation and treatment of depression, psychosis, and dementia in parkinson disease (an evidence-based review) : Report of the quality standards subcommittee of the american academy of neurology
Identifieur interne : 002911 ( Main/Exploration ); précédent : 002910; suivant : 002912Practice Parameter:Evaluation and treatment of depression, psychosis, and dementia in parkinson disease (an evidence-based review) : Report of the quality standards subcommittee of the american academy of neurology
Auteurs : J. M. Miyasaki [Canada] ; K. Shannon [États-Unis] ; V. Voon [États-Unis] ; B. Ravina [États-Unis] ; G. Kleiner-Fisman [États-Unis] ; K. Anderson [États-Unis] ; L. M. Shulman [États-Unis] ; G. Gronseth [États-Unis] ; W. J. Weiner [États-Unis]Source :
- Neurology [ 0028-3878 ] ; 2006.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Neurologie.
English descriptors
- KwdEn :
Abstract
Objective: To make evidence-based treatment recommendations for patients with Parkinson disease (PD) with dementia, depression, and psychosis based on these questions: 1) What tools are effective to screen for depression, psychosis, and dementia in PD? 2) What are effective treatments for depression and psychosis in PD? 3) What are effective treatments for PD dementia or dementia with Lewy bodies (DLB)? Methods: A nine-member multispecialty committee evaluated available evidence from a structured literature review using MEDLINE, and the Cochrane Database of Health and Psychosocial Instruments from 1966 to 2004. Additional articles were identified by panel members. Results: The Beck Depression Inventory-I, Hamilton Depression Rating Scale, and Montgomery Asberg Depression Rating Scale should be considered to screen for depression in PD (Level B). The Mini-Mental State Examination and the Cambridge Cognitive Examination should be considered to screen for dementia in PD (Level B). Amitriptyline may be considered to treat depression in PD without dementia (Level C). For psychosis in PD, clozapine should be considered (Level B), quetiapine may be considered (Level C), but olanzapine should not be considered (Level B). Donepezil or rivastigmine should be considered for dementia in PD (Level B) and rivastigmine should be considered for DLB (Level B). Conclusions: Screening tools are available for depression and dementia in patients with PD, but more specific validated tools are needed. There are no widely used, validated tools for psychosis screening in Parkinson disease (PD). Clozapine successfully treats psychosis in PD. Cholinesterase inhibitors are effective treatments for dementia in PD, but improvement is modest and motor side effects may occur.
Affiliations:
- Canada, États-Unis
- Kansas, Maryland, Ontario, Pennsylvanie
- Baltimore, College Park (Maryland), Lawrence (Kansas), Philadelphie, Toronto
- Université de Toronto, Université du Kansas, Université du Maryland
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000840
- to stream PascalFrancis, to step Curation: 000483
- to stream PascalFrancis, to step Checkpoint: 000705
- to stream Main, to step Merge: 002C03
- to stream Main, to step Curation: 002911
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Practice Parameter:Evaluation and treatment of depression, psychosis, and dementia in parkinson disease (an evidence-based review) : Report of the quality standards subcommittee of the american academy of neurology</title><author><name sortKey="Miyasaki, J M" sort="Miyasaki, J M" uniqKey="Miyasaki J" first="J. M." last="Miyasaki">J. M. Miyasaki</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>University of Toronto</s1><s3>CAN</s3><sZ>1 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation></author><author><name sortKey="Shannon, K" sort="Shannon, K" uniqKey="Shannon K" first="K." last="Shannon">K. Shannon</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Rush University Medical Center</s1><s2>Chicago, IL</s2><s3>USA</s3><sZ>2 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Rush University Medical Center</wicri:noRegion></affiliation></author><author><name sortKey="Voon, V" sort="Voon, V" uniqKey="Voon V" first="V." last="Voon">V. Voon</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>NIH</s1><s2>Bethesda, MD</s2><s3>USA</s3><sZ>3 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>NIH</wicri:noRegion></affiliation></author><author><name sortKey="Ravina, B" sort="Ravina, B" uniqKey="Ravina B" first="B." last="Ravina">B. Ravina</name><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>University of Rochester</s1><s2>NY</s2><s3>USA</s3><sZ>4 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>University of Rochester</wicri:noRegion></affiliation></author><author><name sortKey="Kleiner Fisman, G" sort="Kleiner Fisman, G" uniqKey="Kleiner Fisman G" first="G." last="Kleiner-Fisman">G. Kleiner-Fisman</name><affiliation wicri:level="3"><inist:fA14 i1="05"><s1>University of Pennsylvania</s1><s2>Philadelphia</s2><s3>USA</s3><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Philadelphie</settlement><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Anderson, K" sort="Anderson, K" uniqKey="Anderson K" first="K." last="Anderson">K. Anderson</name><affiliation wicri:level="4"><inist:fA14 i1="06"><s1>University of Maryland</s1><s2>Baltimore</s2><s3>USA</s3><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>9 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Baltimore</settlement><region type="state">Maryland</region><settlement type="city">College Park (Maryland)</settlement></placeName><orgName type="university">Université du Maryland</orgName></affiliation></author><author><name sortKey="Shulman, L M" sort="Shulman, L M" uniqKey="Shulman L" first="L. M." last="Shulman">L. M. Shulman</name><affiliation wicri:level="4"><inist:fA14 i1="06"><s1>University of Maryland</s1><s2>Baltimore</s2><s3>USA</s3><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>9 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Baltimore</settlement><region type="state">Maryland</region><settlement type="city">College Park (Maryland)</settlement></placeName><orgName type="university">Université du Maryland</orgName></affiliation></author><author><name sortKey="Gronseth, G" sort="Gronseth, G" uniqKey="Gronseth G" first="G." last="Gronseth">G. Gronseth</name><affiliation wicri:level="4"><inist:fA14 i1="07"><s1>University of Kansas</s1><s2>Kansas City</s2><s3>USA</s3><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Lawrence (Kansas)</settlement><region type="state">Kansas</region></placeName><orgName type="university">Université du Kansas</orgName></affiliation></author><author><name sortKey="Weiner, W J" sort="Weiner, W J" uniqKey="Weiner W" first="W. J." last="Weiner">W. J. Weiner</name><affiliation wicri:level="4"><inist:fA14 i1="06"><s1>University of Maryland</s1><s2>Baltimore</s2><s3>USA</s3><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>9 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Baltimore</settlement><region type="state">Maryland</region><settlement type="city">College Park (Maryland)</settlement></placeName><orgName type="university">Université du Maryland</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">06-0225669</idno><date when="2006">2006</date><idno type="stanalyst">PASCAL 06-0225669 INIST</idno><idno type="RBID">Pascal:06-0225669</idno><idno type="wicri:Area/PascalFrancis/Corpus">000840</idno><idno type="wicri:Area/PascalFrancis/Curation">000483</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000705</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000705</idno><idno type="wicri:doubleKey">0028-3878:2006:Miyasaki J:practice:parameter:evaluation</idno><idno type="wicri:Area/Main/Merge">002C03</idno><idno type="wicri:Area/Main/Curation">002911</idno><idno type="wicri:Area/Main/Exploration">002911</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Practice Parameter:Evaluation and treatment of depression, psychosis, and dementia in parkinson disease (an evidence-based review) : Report of the quality standards subcommittee of the american academy of neurology</title><author><name sortKey="Miyasaki, J M" sort="Miyasaki, J M" uniqKey="Miyasaki J" first="J. M." last="Miyasaki">J. M. Miyasaki</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>University of Toronto</s1><s3>CAN</s3><sZ>1 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation></author><author><name sortKey="Shannon, K" sort="Shannon, K" uniqKey="Shannon K" first="K." last="Shannon">K. Shannon</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Rush University Medical Center</s1><s2>Chicago, IL</s2><s3>USA</s3><sZ>2 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Rush University Medical Center</wicri:noRegion></affiliation></author><author><name sortKey="Voon, V" sort="Voon, V" uniqKey="Voon V" first="V." last="Voon">V. Voon</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>NIH</s1><s2>Bethesda, MD</s2><s3>USA</s3><sZ>3 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>NIH</wicri:noRegion></affiliation></author><author><name sortKey="Ravina, B" sort="Ravina, B" uniqKey="Ravina B" first="B." last="Ravina">B. Ravina</name><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>University of Rochester</s1><s2>NY</s2><s3>USA</s3><sZ>4 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>University of Rochester</wicri:noRegion></affiliation></author><author><name sortKey="Kleiner Fisman, G" sort="Kleiner Fisman, G" uniqKey="Kleiner Fisman G" first="G." last="Kleiner-Fisman">G. Kleiner-Fisman</name><affiliation wicri:level="3"><inist:fA14 i1="05"><s1>University of Pennsylvania</s1><s2>Philadelphia</s2><s3>USA</s3><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Philadelphie</settlement><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Anderson, K" sort="Anderson, K" uniqKey="Anderson K" first="K." last="Anderson">K. Anderson</name><affiliation wicri:level="4"><inist:fA14 i1="06"><s1>University of Maryland</s1><s2>Baltimore</s2><s3>USA</s3><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>9 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Baltimore</settlement><region type="state">Maryland</region><settlement type="city">College Park (Maryland)</settlement></placeName><orgName type="university">Université du Maryland</orgName></affiliation></author><author><name sortKey="Shulman, L M" sort="Shulman, L M" uniqKey="Shulman L" first="L. M." last="Shulman">L. M. Shulman</name><affiliation wicri:level="4"><inist:fA14 i1="06"><s1>University of Maryland</s1><s2>Baltimore</s2><s3>USA</s3><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>9 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Baltimore</settlement><region type="state">Maryland</region><settlement type="city">College Park (Maryland)</settlement></placeName><orgName type="university">Université du Maryland</orgName></affiliation></author><author><name sortKey="Gronseth, G" sort="Gronseth, G" uniqKey="Gronseth G" first="G." last="Gronseth">G. Gronseth</name><affiliation wicri:level="4"><inist:fA14 i1="07"><s1>University of Kansas</s1><s2>Kansas City</s2><s3>USA</s3><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Lawrence (Kansas)</settlement><region type="state">Kansas</region></placeName><orgName type="university">Université du Kansas</orgName></affiliation></author><author><name sortKey="Weiner, W J" sort="Weiner, W J" uniqKey="Weiner W" first="W. J." last="Weiner">W. J. Weiner</name><affiliation wicri:level="4"><inist:fA14 i1="06"><s1>University of Maryland</s1><s2>Baltimore</s2><s3>USA</s3><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>9 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Baltimore</settlement><region type="state">Maryland</region><settlement type="city">College Park (Maryland)</settlement></placeName><orgName type="university">Université du Maryland</orgName></affiliation></author></analytic><series><title level="j" type="main">Neurology</title><title level="j" type="abbreviated">Neurology</title><idno type="ISSN">0028-3878</idno><imprint><date when="2006">2006</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Neurology</title><title level="j" type="abbreviated">Neurology</title><idno type="ISSN">0028-3878</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>American</term><term>Dementia</term><term>Depression</term><term>Evaluation</term><term>Nervous system diseases</term><term>Neurology</term><term>Parkinson disease</term><term>Psychosis</term><term>Treatment</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term><term>Etat dépressif</term><term>Psychose</term><term>Démence</term><term>Parkinson maladie</term><term>Evaluation</term><term>Traitement</term><term>Américain</term><term>Neurologie</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Neurologie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Objective: To make evidence-based treatment recommendations for patients with Parkinson disease (PD) with dementia, depression, and psychosis based on these questions: 1) What tools are effective to screen for depression, psychosis, and dementia in PD? 2) What are effective treatments for depression and psychosis in PD? 3) What are effective treatments for PD dementia or dementia with Lewy bodies (DLB)? Methods: A nine-member multispecialty committee evaluated available evidence from a structured literature review using MEDLINE, and the Cochrane Database of Health and Psychosocial Instruments from 1966 to 2004. Additional articles were identified by panel members. Results: The Beck Depression Inventory-I, Hamilton Depression Rating Scale, and Montgomery Asberg Depression Rating Scale should be considered to screen for depression in PD (Level B). The Mini-Mental State Examination and the Cambridge Cognitive Examination should be considered to screen for dementia in PD (Level B). Amitriptyline may be considered to treat depression in PD without dementia (Level C). For psychosis in PD, clozapine should be considered (Level B), quetiapine may be considered (Level C), but olanzapine should not be considered (Level B). Donepezil or rivastigmine should be considered for dementia in PD (Level B) and rivastigmine should be considered for DLB (Level B). Conclusions: Screening tools are available for depression and dementia in patients with PD, but more specific validated tools are needed. There are no widely used, validated tools for psychosis screening in Parkinson disease (PD). Clozapine successfully treats psychosis in PD. Cholinesterase inhibitors are effective treatments for dementia in PD, but improvement is modest and motor side effects may occur.</div></front></TEI><affiliations><list><country><li>Canada</li><li>États-Unis</li></country><region><li>Kansas</li><li>Maryland</li><li>Ontario</li><li>Pennsylvanie</li></region><settlement><li>Baltimore</li><li>College Park (Maryland)</li><li>Lawrence (Kansas)</li><li>Philadelphie</li><li>Toronto</li></settlement><orgName><li>Université de Toronto</li><li>Université du Kansas</li><li>Université du Maryland</li></orgName></list><tree><country name="Canada"><region name="Ontario"><name sortKey="Miyasaki, J M" sort="Miyasaki, J M" uniqKey="Miyasaki J" first="J. M." last="Miyasaki">J. M. Miyasaki</name></region></country><country name="États-Unis"><noRegion><name sortKey="Shannon, K" sort="Shannon, K" uniqKey="Shannon K" first="K." last="Shannon">K. Shannon</name></noRegion><name sortKey="Anderson, K" sort="Anderson, K" uniqKey="Anderson K" first="K." last="Anderson">K. Anderson</name><name sortKey="Gronseth, G" sort="Gronseth, G" uniqKey="Gronseth G" first="G." last="Gronseth">G. Gronseth</name><name sortKey="Kleiner Fisman, G" sort="Kleiner Fisman, G" uniqKey="Kleiner Fisman G" first="G." last="Kleiner-Fisman">G. Kleiner-Fisman</name><name sortKey="Ravina, B" sort="Ravina, B" uniqKey="Ravina B" first="B." last="Ravina">B. Ravina</name><name sortKey="Shulman, L M" sort="Shulman, L M" uniqKey="Shulman L" first="L. M." last="Shulman">L. M. Shulman</name><name sortKey="Voon, V" sort="Voon, V" uniqKey="Voon V" first="V." last="Voon">V. Voon</name><name sortKey="Weiner, W J" sort="Weiner, W J" uniqKey="Weiner W" first="W. J." last="Weiner">W. J. Weiner</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002911 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002911 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:06-0225669
|texte= Practice Parameter:Evaluation and treatment of depression, psychosis, and dementia in parkinson disease (an evidence-based review) : Report of the quality standards subcommittee of the american academy of neurology
}}
| This area was generated with Dilib version V0.6.29. |  |